Literature DB >> 28518069

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors.

Tobias G Kapp1, Maximilian Fottner2, Horst Kessler2.   

Abstract

The guanidine group is one of the most important pharmacophoric groups in medicinal chemistry. The only amino acid carrying a guanidine group is arginine. In this article, an easy method for the modification of the guanidine group in peptidic ligands is provided, with an example of RGD-binding integrin ligands. It was recently demonstrated that the distinct modification of the guanidine group in these ligands allows for the selective modulation of the subtype (e.g., between the subtypes αv and α5). Moreover, a formerly unknown strategy for the functionalization via the guanidine group was demonstrated, and the synthetic approach is reviewed in this document. The modifications described here involve terminally (Nω) alkylated and acetylated guanidine groups. For the synthesis, tailor-made precursor molecules are synthesized, which are then subjected to a reaction with an orthogonally deprotected amine to transfer the pre-modified guanidine group. For the synthesis of alkylated guanidines, precursors based on N,N'-Di-Boc-1H-pyrazole-1-carboxamidine are used to synthesize acylated compounds, the precursor of choice being a correspondingly acylated derivative of N-Boc-S-methylisothiourea, which can be obtained in one- and two-step reactions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28518069      PMCID: PMC5565116          DOI: 10.3791/54873

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

Review 1.  Ligand binding to integrins.

Authors:  E F Plow; T A Haas; L Zhang; J Loftus; J W Smith
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

2.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

Review 3.  RGD modified polymers: biomaterials for stimulated cell adhesion and beyond.

Authors:  Ulrich Hersel; Claudia Dahmen; Horst Kessler
Journal:  Biomaterials       Date:  2003-11       Impact factor: 12.479

4.  Conformational control of integrin-subtype selectivity in isoDGR peptide motifs: a biological switch.

Authors:  Andreas O Frank; Elke Otto; Carlos Mas-Moruno; Herbert B Schiller; Luciana Marinelli; Sandro Cosconati; Alexander Bochen; Dörte Vossmeyer; Grit Zahn; Roland Stragies; Ettore Novellino; Horst Kessler
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-22       Impact factor: 15.336

Review 5.  Integrins: bidirectional, allosteric signaling machines.

Authors:  Richard O Hynes
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

Review 6.  Biological activities of guanidine compounds.

Authors:  Franciszek Saczewski; Łukasz Balewski
Journal:  Expert Opin Ther Pat       Date:  2009-10       Impact factor: 6.674

Review 7.  Biological activities of guanidine compounds, 2008 - 2012 update.

Authors:  Franciszek Sączewski; Łukasz Balewski
Journal:  Expert Opin Ther Pat       Date:  2013-04-25       Impact factor: 6.674

8.  N(G)-Acyl-argininamides as NPY Y(1) receptor antagonists: Influence of structurally diverse acyl substituents on stability and affinity.

Authors:  Stefan Weiss; Max Keller; Günther Bernhardt; Armin Buschauer; Burkhard König
Journal:  Bioorg Med Chem       Date:  2010-07-16       Impact factor: 3.641

9.  Photoswitched cell adhesion on surfaces with RGD peptides.

Authors:  Jörg Auernheimer; Claudia Dahmen; Ulrich Hersel; Andreas Bausch; Horst Kessler
Journal:  J Am Chem Soc       Date:  2005-11-23       Impact factor: 15.419

10.  Small Cause, Great Impact: Modification of the Guanidine Group in the RGD Motif Controls Integrin Subtype Selectivity.

Authors:  Tobias G Kapp; Maximilian Fottner; Oleg V Maltsev; Horst Kessler
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-09       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.